LifeStance Health Group, Inc. specializes in delivering outpatient mental healthcare services through its subsidiary network. The company offers a comprehensive array of mental health solutions, encompassing psychiatric evaluations and treatment, specialized psychological and neuropsychological testing, and diverse therapeutic modalities including individual, family, and group therapy sessions. The organization addresses a wide spectrum of mental health conditions, ranging from common issues like anxiety and depression to more complex challenges such as bipolar disorder, eating disorders,…
11 analysts rate LFST Buy on consensus.
Consensus price target: $14.40 (+11.37% upside from $12.93)
| Insider | Date | Transaction | Shares | Value |
|---|---|---|---|---|
| Paunovich Vukasin Chief Technology Officer | Sep 2, 2026 | Sale | 42,067 | $541.4K |
| DeLuca Teresa director | Aug 13, 2026 | Sale | 20,441 | $249.99K |
| Burdick Kenneth A director | Aug 11, 2026 | Sale | 500,000 | $5.76M |
| Miller Lisa K Chief Operating Officer | Aug 10, 2026 | Sale | 47,912 | $519.85K |
| Paunovich Vukasin Chief Technology Officer | Aug 10, 2026 | Sale | 44,394 | $481.67K |
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2025 | $1.42B | +13.85% | $9.66M |
| 2024 | $1.25B | +18.5% | $-57.44M |
| 2023 | $1.06B | +22.82% | $-186.26M |
Stock data for LFST: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics